{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:07:50Z","timestamp":1784117270818,"version":"3.55.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>5-Aminolevulinic acid hydrochloride (5-ALA), a photodynamic diagnostic agent, visualizes bladder cancer. Previous research has indicated that preoperative intake of 5-ALA leads to a higher incidence of hypotension. Particularly in patients with hypertension, suggestions include discontinuing antihypertensive medications on the morning of surgery to prevent hypotension. However, the effects of antihypertensive drugs on hypotension in patients taking 5-ALA before surgery remains unexamined. We conducted a single-center observational study that included patients aged 20 and above who were regularly taking antihypertensives and underwent transurethral resection of bladder tumors (TURBT) after taking 5-ALA. Patients who took antihypertensives on the morning of surgery were defined as the continued group, whereas those who did not were defined as the discontinued group. Hypotension was defined as a mean blood pressure (MBP) of less than 65 mmHg for 20\u2009min or longer. To adjust for confounding factors, we used propensity scores for inverse probability weighting and performed modified Poisson regression analysis to calculate risk ratios (RRs) and 95% confidence intervals (CIs). We analyzed 132 cases. The crude incidence of hypotension was higher in the continued group compared to the discontinued group (33\/51 [64.7%] vs 38\/81 [46.9%]; RR 1.38, 95% CI 1.01\u20131.88; p =\u2009 0.041). However, no significant difference was observed between groups after adjustment (RR 1.05, 95% CI 0.66\u20131.68). In conclusion, the adjusted results suggested no significant association between the continuation of antihypertensive medication and the incidence of intraoperative hypotension. No substantial justification was provided for routinely discontinuing antihypertensive medications.<\/jats:p>","DOI":"10.1371\/journal.pone.0319413","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T18:30:09Z","timestamp":1740421809000},"page":"e0319413","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preoperative antihypertensives and hypotension during bladder tumor resection with oral 5-aminolevulinic acid administration"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-6494","authenticated-orcid":true,"given":"Yuriko","family":"Kondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0613-511X","authenticated-orcid":true,"given":"Takahiro","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanako","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Echigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-5007","authenticated-orcid":true,"given":"Yusuke","family":"Nagamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"issue":"2","key":"pone.0319413.ref001","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pdpdt.2015.03.008","article-title":"Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: a randomized, double-blind, multicentre phase II\/III study","volume":"12","author":"K Inoue","year":"2015","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"pone.0319413.ref002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1213\/XAA.0000000000001128","article-title":"Severe and prolonged hypotension after oral 5-aminolevulinic acid administration in a patient with end-stage renal disease undergoing transurethral resection of a bladder tumor: a case report","volume":"14","author":"T Kida","year":"2020","journal-title":"A A Pract"},{"issue":"1","key":"pone.0319413.ref003","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40981-019-0295-1","article-title":"Preanesthetic severe postural hypotension following 5-aminolevulinic acid pretreatment in patients for photodynamic diagnosis-assisted urological surgery","volume":"5","author":"T Shiratori","year":"2019","journal-title":"JA Clin Rep"},{"issue":"1","key":"pone.0319413.ref004","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40981-019-0279-1","article-title":"5-Aminolevulinic acid-induced severe hypotension during transurethral resection of a bladder tumor: a case report","volume":"5","author":"T Yatabe","year":"2019","journal-title":"JA Clin Rep"},{"issue":"4","key":"pone.0319413.ref005","first-page":"374","article-title":"Differences in 5- aminolevulinic acid-induced hemodynamic changes between patients undergoing neurosurgery and urological surgery","volume":"4","author":"T Shiratori","year":"2021","journal-title":"JMA J"},{"key":"pone.0319413.ref006","doi-asserted-by":"crossref","first-page":"102342","DOI":"10.1016\/j.pdpdt.2021.102342","article-title":"Oral 5-aminolevulinic acid administration prior to transurethral resection of bladder tumor causes intraoperative hypotension: Propensity score analysis","volume":"34","author":"S Nakatani","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"pone.0319413.ref007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40981-020-00399-4","article-title":"Hypotension caused by oral administration of 5-aminolevulinic acid persists after surgery in patients undergoing transurethral resection of bladder tumor under spinal anesthesia","volume":"6","author":"M Sato","year":"2020","journal-title":"JA Clin Rep"},{"issue":"11","key":"pone.0319413.ref008","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/iju.14099","article-title":"Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer","volume":"26","author":"T Nohara","year":"2019","journal-title":"Int J Urol"},{"issue":"1","key":"pone.0319413.ref009","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1186\/s12885-021-08976-1","article-title":"Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: a multicenter retrospective study","volume":"21","author":"Japan Urological Photodynamic Society","year":"2021","journal-title":"BMC Cancer"},{"key":"pone.0319413.ref010","doi-asserted-by":"crossref","first-page":"102179","DOI":"10.1016\/j.pdpdt.2021.102179","article-title":"Impact of age, body mass index, and renal function for severe hypotension caused by oral 5-aminolevulinic acid administration in patients undergoing transurethral resection of bladder tumor","volume":"33","author":"J Miyakawa","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"pone.0319413.ref011","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40981-020-00340-9","article-title":"Identification of risk factors for post-induction hypotension in patients receiving 5-aminolevulinic acid: a single-center retrospective study","volume":"6","author":"T Yatabe","year":"2020","journal-title":"JA Clin Rep"},{"issue":"1","key":"pone.0319413.ref012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pdpdt.2012.06.004","article-title":"Oral 5-aminolevulinic acid induced photodynamic diagnostic ureterorenoscopy--does the blood pressure require monitoring?","volume":"10","author":"J Bondad","year":"2013","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"4","key":"pone.0319413.ref013","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pdpdt.2013.03.007","article-title":"Risk factors for developing oral 5-aminolevulinic acid-induced side effects in patients undergoing fluorescence guided resection","volume":"10","author":"IW Chung","year":"2013","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"2","key":"pone.0319413.ref014","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pdpdt.2012.11.008","article-title":"Diagnosis of upper urinary tract tumours: is photodynamic diagnosis assisted ureterorenoscopy required as an addition to modern imaging and ureterorenoscopy?","volume":"10","author":"OM Aboumarzouk","year":"2013","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"2","key":"pone.0319413.ref015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.aju.2017.01.003","article-title":"Photodynamic diagnosis in upper urinary tract urothelial carcinoma: a systematic review","volume":"15","author":"E Osman","year":"2017","journal-title":"Arab J Urol"},{"issue":"8","key":"pone.0319413.ref016","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"STROBE Initiative","year":"2007","journal-title":"Ann Intern Med"},{"issue":"5","key":"pone.0319413.ref017","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bja.2019.01.013","article-title":"Perioperative quality initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery","volume":"122","author":"Perioperative Quality Initiative-3 workgroup","year":"2019","journal-title":"Br J Anaesth"},{"issue":"4","key":"pone.0319413.ref018","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bja.2018.04.036","article-title":"Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review","volume":"121","author":"EM Wesselink","year":"2018","journal-title":"Br J Anaesth"},{"issue":"5","key":"pone.0319413.ref019","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bja.2019.01.019","article-title":"Perioperative quality initiative consensus statement on postoperative blood pressure, risk and outcomes for elective surgery","volume":"122","author":"POQI-3 workgroup","year":"2019","journal-title":"Br J Anaesth"},{"issue":"1","key":"pone.0319413.ref020","first-page":"1","article-title":"KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","journal-title":"Kidney Inter Suppl"},{"issue":"9","key":"pone.0319413.ref021","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1253\/circj.CJ-22-0609","article-title":"JCS 2022 guideline on perioperative cardiovascular assessment and management for non-cardiac surgery","volume":"87","author":"Japanese Society Joint Working Group","year":"2023","journal-title":"Circ J"},{"issue":"1","key":"pone.0319413.ref022","first-page":"1","article-title":"KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Inter Suppl"},{"issue":"1","key":"pone.0319413.ref023","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"KY Liang","year":"1986","journal-title":"Biometrika"},{"issue":"2","key":"pone.0319413.ref024","first-page":"1","article-title":"The R Package geepack for generalized estimating equations","volume":"15","author":"S Hojsgaard","year":"2006","journal-title":"J Stat Softw"},{"issue":"23","key":"pone.0319413.ref025","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"LE Thomas","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"pone.0319413.ref026","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12871-022-01899-9","article-title":"Predictors of hypotension during anesthesia induction in patients with hypertension on medication: a retrospective observational study","volume":"22","author":"T Hojo","year":"2022","journal-title":"BMC Anesthesiol"},{"issue":"3","key":"pone.0319413.ref027","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4103\/0970-9185.98373","article-title":"Severe hypotension following spinal anesthesia in patients on amlodipine","volume":"28","author":"S Parida","year":"2012","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"3","key":"pone.0319413.ref028","doi-asserted-by":"crossref","first-page":"L337","DOI":"10.1152\/ajplung.00482.2005","article-title":"Protoporphyrin IX generation from delta-aminolevulinic acid elicits pulmonary artery relaxation and soluble guanylate cyclase activation","volume":"291","author":"CJ Mingone","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"pone.0319413.ref029","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00345-011-0788-7","article-title":"Hemodynamic effects of orally administered delta-ALA during radical prostatectomy","volume":"31","author":"V Eichhorn","year":"2013","journal-title":"World J Urol"},{"key":"pone.0319413.ref030","unstructured":"SBI Pharmaceuticals Co., Ltd. In: SBI Pharma [Internet]. Feb 2023 [cited 30 Nov 2023]. Available from: https:\/\/www.sbipharma.co.jp\/business\/medicine\/pharmaceutical-information\/alaglio-1-5g\/"},{"issue":"8","key":"pone.0319413.ref031","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/iju.13718","article-title":"Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: a multicenter phase III study","volume":"25","author":"Y Nakai","year":"2018","journal-title":"Int J Urol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T18:30:20Z","timestamp":1740421820000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319413"}},"subtitle":[],"editor":[{"given":"Andr\u00e9 Prato","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0319413","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]}}}